Oppenheimer Holdings Inc. (OPY)

The investment thesis here rests on a powerful divergence between a deteriorating short-term trend and a fundamentally robust long-term business. Over the last two weeks, the stock has struggled, trading below its 50-day moving average with a recent dip to $104, which suppresses immediate momentum. However, the long-term picture is compelling: the company has delivered a massive +316% cumulative return over the past nine years, driven by seven consecutive years of positive annual growth. The most recent year saw a robust +29% gain, and the trailing twelve-month revenue growth stands at a healthy 23%. Fundamentally, Oppenheimer is trading at a bargain valuation with a P/E of roughly 14 and a price-to-book ratio of just 1.3, while maintaining a fortress-like payout ratio of only 8.6%, leaving ample room for future dividend increases. The disconnect between the weak recent price action and the strong underlying earnings suggests the market may be overreacting to temporary headwinds or the class-action settlement news. While the short-term outlook remains cautious due to the lack of immediate catalysts to reverse the downtick, the long-term fundamentals—sustained growth, low valuation, and strong cash generation—make this a solid buy-and-hold candidate for patient capital.